This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

RAN-RISPERIDONE

RANBAXY PHARMACEUTICALS CANADA INC.

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RAN-RISPERIDONE in Canada?

Yes. RAN-RISPERIDONE 3.0MG has an active shortage reported to Health Canada (last updated November 11, 2025).

Why is RAN-RISPERIDONE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will RAN-RISPERIDONE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength3.0MG

Last updated2019-08-10

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

RISPERDAL ORAL SOLUTION

JANSSEN INC

1MG · DIN 02236950

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PMS-RISPERIDONE

PHARMASCIENCE INC

0.25MG · DIN 02252007

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ACT RISPERIDONE

ACTAVIS PHARMA COMPANY

0.25MG · DIN 02282585

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-RISPERIDONE

APOTEX INC

2.0MG · DIN 02282143

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RISPERDAL M-TAB

JANSSEN INC

1MG · DIN 02247705

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RATIO-RISPERIDONE

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

0.25MG · DIN 02264757

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02328364

Strength

3.0MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

RISPERIDONE

Tier

Unrated

Last Updated

2019-08-10

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

RAN-RISPERIDONE has 3 shortage/discontinuation reports on file — this is one of them.

2026-07-16

Permanently Discontinued

Business reasons

2025-11-11

Active Shortage

Disruption of the manufacture of the drug.

Other Products from RANBAXY PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

RAN-CITALO

40MG · DIN 02285630

RAN-CITALO

20MG · DIN 02285622

RAN-FENTANYL MATRIX PATCH

25MCG · DIN 02330113

RAN-FENTANYL MATRIX PATCH

75MCG · DIN 02330148

RAN-FENTANYL MATRIX PATCH

50MCG · DIN 02330121

RAN-FENTANYL MATRIX PATCH

100MCG · DIN 02330156